By Jeya Chelliah, B.VSc, Ph.D | Published by eScience

📘 About the Author

Dr. Jeya Chelliah, Ph.D. in Biochemistry & Immunology from King’s College London, is a cancer researcher and the Editor of eScience, an online scientific publication recognized for delivering innovative research insights.

🧠 What’s Inside the eBook

✔️ Scientific rationale for MHC downregulation in tumors
✔️ Complete overview of CRISPR-based epigenetic reprogramming
✔️ Full experimental protocol (materials, steps, validation)
✔️ Troubleshooting guide & expected outcomes
✔️ NIH-style grant proposal & funding resources
✔️ Future research directions and biotech opportunities
✔️ Literature-backed with citations and real-world examples

Why This Idea Is Unique

This is the first approach that uses CRISPR-based epigenome editing—without altering the genome—to restore MHC expression in tumors. It combines safety, specificity, and innovation to open new doors in immunotherapy. No other published work offers this complete strategy and protocol.

         💵 Buy Now – Just $49

For inquiries or additional details, contact: jeya@escienceinfo.com